PersImmune, Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN) (NCT03258359) | PersImmune, Inc | 2018-01-01 |
Track PersImmune, Inc automatically
Every clearance here is in the API, with alerts when new ones post.